Children who survive a stem-cell transplant only to watch their own donor cells attack their organs now have a ...
CAMBRIDGE, Mass., July 8, 2026 /PRNewswire/ -- MEDIPOST Inc., a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies for inflammation-driven degenerative ...
BBG Advanced Therapies, a subsidiary of San Antonio-based nonprofit BioBridge Global, today announced a collaboration ...
A study led by a researcher based at King's College London and McMaster University in Canada reveals how CAR-T cell therapy, a treatment that engineers a patient's own immune cells to recognize and ...
Americans Skip Overseas Travel as Stem Cell Therapy Arrives at 5 U.S. Locations Aventura, United States - July 5, 2026 ...
The FDA has approved an allogeneic regulatory T cell immunotherapy for use in matched-donor hematopoietic stem cell transplantation in patients with blood cancers, to improve survival for chronic ...
A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...
Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that centers ...
Americans Skip Overseas Trips as Stem Cell Exosome Therapy Arrives at 5 Domestic Locations Aventura, United States - ...